The antimicrobial potential of Lactobacillus acidophilus on pathogenic bacteria causing diarrhea

Authors

  • Rasha H. Bassyouni Fayoum University
  • Mohammed Wasim Ahmed Nassar Cairo University
  • Zeinab Abdelkhalek Ibrahim Cairo University
  • Mohammed Saad Zaghloul Ahmed Fayoum University

DOI:

https://doi.org/10.3823/764

Keywords:

Probiotic, L. acidophilus, Bacterial Diarrhea

Abstract

Object: Lactobacillus acidophilus is a nonpathogenic member of gastrointestinal tract and it is widely used in fermented dairy products. This study aimed to assess the antimicrobial potential of two strains of L. acidophilus on some pathogenic bacteria frequently causing diarrhea or gastroenteritis.

Methods: The antibacterial activity cell free supernatant (CFS) of two control standard strains of L. acidophilus (L. acidophilus-la5 and L. acidophilus against fie control standard strains of bacteria causing diarrhea; Enterotoxogenic Escherichia coli (ETEC), Enterohaemorrhagic E. coli O 157:H7(EHEC) Salmonella typhimurium Shigella flxeneri and Staphylococcus aureus were determined using agar well diffusion method. The sensitivity of the pathogenic bacteria to the CFS of each L. acidophilus in relation to time was determined by standard plate count .The antibiotic susceptibility tests of 20 antibiotics against tested organisms with and without CFS were assessed by disc diffusion method. The minimum inhibitory concentration (MIC) of ciproflxacin with and without CFS was determined by tube dilution method.

Results: Both Lactobacilli strains decrease the colony count of tested strains by more than 90% after 60 min contact time. Both Lactobacilli strains signifiantly improve the antibacterial effect of tested antibiotics against ETEC, S. typhimurium and S. aureus, and S. flxeneri (P< 0.05). The MIC of ciproflxacin alone against all tested strains was 15.625 μg/ml, while when combined with both Lactobacilli CFSs, the MIC decreased signifiantly to 0.488 μg/ml for ETEC, S. typhimurium, and S. flxeneri and to 0.977 μg/ml for EHEC and S. aureus (P= 0.000).

Conclusion: living L. acidophilus strains could be used in prevention and treatment of diarrhea caused by certain bacterial pathogens, either in fermented milk/ yoghurt or as mediations.

References

References:

Kolader ME, Vinh H,,Tuyet PTN,Thompson C, Wolbers M,Merson L, et al. An oral preparation of Lactobacillus acidophilus for the treatment of uncomplicated acute watery diarrhoea in Vietnamese children: study protocol for a multicentre, randomised, placebo-controlled trial. Trials. 2013; 14: 27

DuPont HL. Acute Infectious Diarrhea in Immunocompetent Adults. N Engl J Med 2014; 370:1532-1540

Allen SJ, Martinez EG, Gregorio GV, Dans LF.Probiotics for treating acute infectious diarrhoea. Sao Paulo Med. J. 2011; 129, (3):185-185

Bassyouni.RH, Abdel-all WS, Fadl MG, Abdel-all S, kamel Z. Characterization of Lactic Acid Bacteria Isolated from Dairy Products in Egypt as a Probiotic. Life Science Journal. 2012; 9(4): 2924-2933

Shaukat A, Levitt MD, Taylor BC, MacDonald R, Shamliyan TA, Kane RL, Wilt TJ: Systematic review: effective management strategies for lactose intolerance. Ann Intern Med. 2010; 152:797-803

Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH: Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2011; 11:CD004827.

Fang SB, Lee HC, Hu JJ, Hou SY, Liu HL, Fang HW: Dose-dependent effect of Lactobacillus rhamnosus on quantitative reduction of faecal rotavirus shedding in children.. J Trop Pediatr. 2009; 55:297-301

Phillip, S.,Mtshali, B.D., Maret du Toit. Identification and characterization of Lactobacillus florum strains isolated from South African grape and wine samples International Journal of Food Microbiology. 2010; 153:106-113

Godiosa O. Consignado M.D, Adrian C, Peña M.D, Antonio, V. Jacalne DVM. In Vitro Study on the Antibacterial Activity of Lactobacillus casei (Commercial Yakult Drink) against Four Diarrhea Causing Organisms. Physiological Journal Microbiology Infectious Disease. 1993; 22(2): 50-55.

Vuyst LD, Leroy F. Bacteriocin from lactic acid bacteria: Production, purification and food applications. J Mol Microbiol Biotechnol.2007; 13: 194-199.

Wolf CE, Gibbones WR (1996): Improved method for quantification of the bacteriocin nicin. J Appl Bacteriol.1996; 80: 453–7.

Patton T, Barrett J, Brennan J, Moran N. Use of a spectrophotometricbioassay for determination of microbial sensitivity to manuka honey. J Microbiol Methods. 2006; 64(1): 84-95.

Clinical and Laboratory Standards Institute (CLSI). Performance standards for Antimicrobial Susceptibility Testing. 22 Informational Supplement ed. CLSI 2012. document M100-S22. Wayne, PA.

Ogawa M, Shimizu K, Nomoto K, Tanaka R, Hamabata T, Yamasaki S, et al. Inhibition of in-vitro growth of Shiga toxinproducing Escherichia coli O157-H7 by probiotic Lactobacillus strains due to production of lactic acid .Int J Food Microbiol. 2001; 68: 135–40.

Abdel-Daim A, Hassouna N, Hafez M, Ashor MS, Aboulwafa MM Antagonistic Activity of Lactobacillus Isolates against Salmonella typhi In Vitro. BioMed Research International 2013 (2013), 2013:680605. doi: 10.1155/2013/680605

Zhang Y, Zhang L, Du M, Yi H, Guo C, Tuo Y,et al., (2011): Antimicrobial activity against Shigella sonnei and probiotic properties of wild lactobacilli from fermented food. Microbiol Res. 2011; 167(1): 27-31

Dicks LMN, Botes M. Probiotic lactic acid bacteria in the gastrointestinal tract: health benefits, safety and mode of action. Benef Microbes. 2010; 1: 11-29.

Szymański H, Pejcz J, Jawień M, Chmielarczyk A, Strus M, Heczko PB Treatment of acute infectious diarrhea in infants and children with a mixture of three Lactobacillus rhamnosus strains a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther. 2006; 23(2): 247–53.

Szajewska H, Mrukowicz JZ. Use of probiotics in children with acute diarrhea. Paediatr Drugs. 2005; 7: 111–22.

Tomioka H, Sato K and Saito H. Effect of Ofloxacin Combined with Lactobacillus casei against Mycobacterium fortuitum Infection Induced in Mice. Antimicrob Agents Chemother. 1990; 632-636

Ruiz FO, Gerbaldo G, Asurmendi P, Pascual LM, Giordano W, Barberis IL. Antimicrobial activity, inhibition of urogenital pathogens, and synergistic interactions between lactobacillus strains.Curr Microbiol. 2009;59(5):497-501. doi: 10.1007/s00284-009-9465-0.

Hussein MZ, Gohar YM, Farag W. In-vitro Synergistic Action of Curcumin and Lactobacillus acidophilus with Antibiotics against Helicobacter pylori. Egyptian J. Med. Micobiol. 2007; 3: 521-32

Diniz-Santos DR, Silva LR, Silva N. Antibioticsfor the empirical treatment of acute infectious diarrhea in children Braz J Infect Dis.2006; 10 (3):217-27

Kaur S, Sharma P. Protease-Sensitive Inhibitory Activity of Cell-free Supernatant of Lactobacillus crispatus 156 Synergizes with Ciprofloxacin, Moxifloxacin and Streptomycin Against Pseudomonas aeruginosa: An In Vitro Study. Probiotics Antimicrob Proteins.2015;7(2):172-80.

Downloads

Published

2015-07-18

Issue

Section

Articles